Literature DB >> 22506473

[Transforming growth factor beta1/Smad3 signal transduction pathway and post-traumatic scar formation].

Rong Yu1, Ying Cen.   

Abstract

OBJECTIVE: To summarize the recent progress in related research on transforming growth factor beta1 (TGF-beta1)/Smad3 signal transduction pathway and post-traumatic scar formation.
METHODS: Recent related literature at home and abroad on TGF-beta1/Smad3 signal transduction pathway and post-traumatic scar formation was reviewed and summarized.
RESULTS: TGF-beta1 is an important influence factor of fibrotic diseases, and it plays biological effects by TGF-beta1/ Smad3 signal transduction pathway. The pathway is regulated by many factors and has crosstalk with other signal pathways at cellular and molecular levels. The pathway is involved in the early post-traumatic inflammatory response, wound healing, and late pathological scar formation. Intervening the transduction pathway at the molecular level can influence the process of fibrosis and extracellular matrix deposition.
CONCLUSION: TGF-beta1/Smad3 signal transduction pathway is an important way to affect post-traumatic scar formation and extracellular matrix deposition. The further study on the pathway will provide a theoretical basis for promotion of wound healing, as well as prevention and treatment of pathological scar formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506473

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  2 in total

1.  Preliminary experimental study of urethral reconstruction with tissue engineering and RNA interference techniques.

Authors:  Chao Li; Yue-Min Xu; Hong-Bin Li
Journal:  Asian J Androl       Date:  2013-04-01       Impact factor: 3.285

2.  Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention.

Authors:  Zhi-Ming Tang; Xiao-Xiang Zhai; Ji-Cun Ding
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.